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EXTENDED MATERIALS AND METHODS
Animals and intervention studies LDL receptor-deficient mice (LDLR -/-
) and C57BL/6J were from The Jackson Laboratories (Bar Harbor, Maine, USA); IL-13 -/-mice were a kind gift of Dr. Thomas Wynn (NIAID/NIH, Bethesda, USA). All mice were on a C57BL/6J background and were bred in-house. All experimental protocols were approved by the institutional animal experimentation committee and the Austrian Ministry of Science. Bone marrow transplantation (BMT) studies were performed as previously described (Binder et al, 2004) . Thirty 8-week-old male LDLR -/-mice were given a single dose of 9-Gy lethal total body-irradiation to eliminate endogenous bone marrow stem cells, and irradiated mice were injected intravenously with 2x10 6 bone marrow cells harvested from either IL-13 -/-(n=15) or IL-13 +/+ (n=15) mice. Mice were fed regular chow diet for 4 weeks after BMT to allow for bone marrow reconstitution and then switched to an atherogenic diet containing 21% fat and 0.2% cholesterol (TD88137, Ssniff Spezialdiäten GmbH, Soest, Germany) for an additional 16 weeks to induce lesion formation. Three mice (one in the IL-13 -/-and two in control group) were a priori excluded from final analyses because they developed skin lesions and lost weight, or due to technical problems of tissue collection. One mouse from the control group was excluded as statistical outlier, which however did not alter the statistical significance of the results. For the atherosclerosis intervention study, twenty-four 12 week-old female LDLR -/-mice were fed an atherogenic diet (Ssniff) for a total of 16 weeks to induce lesion formation. At week 11, mice were divided randomly into two groups and injected intraperitoneally with PBS (n=11) or IL-13 (50 ng/mouse R&D systems, Minneapolis, Minnesota, USA; n=13) twice per week for the following remaining 5 weeks. For the isolation of RNA from atherosclerotic lesions present in the aortic arch and valves, sixteen 12 week-old female LDLR -/-mice were fed an atherogenic diet (Ssniff) for a total of 12 weeks to induce lesion formation. At week 8, mice were randomly divided into two groups and injected intraperitoneally with PBS (n=7) or IL-13 (50 ng/mouse R&D systems, n= 9) twice per week for the following remaining 4 weeks.
Evaluation of atherosclerosis
The extent of atherosclerosis was determined in a blinded fashion in en face preparations of the entire aorta, as well as in cross sections through the aortic origin, by computer-assisted image analysis as previously described (Binder et al, 2004) . At time of sacrifice, animals were perfused with PBS, followed by formalin (4% paraformaldehyde in PBS, pH 7.4), and the entire mouse aorta was dissected from the proximal ascending aorta to the bifurcation of the iliac artery. Adventitial fat was removed, and the whole aorta was opened longitudinally, pinned, stained with Sudan IV, and photographed with a digital camera. Total aortic area and aortic lesion area were calculated using Adobe Photoshop CS3 (Adobe Systems, San Jose, California, USA) and ImageJ 1.41 software. Results are reported as percentage of lesion area per total aortic surface area. As a second assessment of atherosclerosis, cross-sections of the aortic origin were quantified for lesion size and phenotype. Serial sections (5 µm in thickness) were cut through a 400 µm segment of the aortic root, starting with the appearance of all 3 valve leaflets. For each mouse, 8 sections separated by 50 µm were examined. Each section was stained with H&E and photographed using the AxioVison software (Carl Zeiss AG, Jena, Germany). Total lesion area was quantified using Adobe Photoshop CS3 and ImageJ 1.41 softwares.
Immunohistochemistry and phenotypic analysis of lesions.
Lesion phenotype was determined by the content of collagen, size of necrotic core area, and the presence of macrophages, smooth-muscle cells, T-cells, classical activated (M1) macrophages, alternatively activated (M2) macrophages, ABCA1 expressing cells, and CCR7 expression in lesions of equal size. For the collagen content, sections were stained with Sirius Red, and for the assessment of necrotic cores, sections were stained with a modified elastictrichrome stain. The photographed images were analyzed using ImageJ 1.41 software to determine the percentage of collagen and necrotic core area, respectively. For the presence of macrophages, smooth-muscle cells, T-cells, M1 macrophages and M2 macrophages immunohistochemistry was performed using antibodies against mouse Mac-3 (1:50 rat antimouse, clone M3/84, BD-Biosciences Pharmingen, San Diego, California, USA), smoothmuscle cell actin (1:10,000 polyclonal rabbit anti-mouse, Sigma-Aldrich), CD3 (1:800 polyclonal rabbit anti-human/mouse, DAKO, Glostrup, Denmark), iNOS (1:500 polyclonal rabbit anti-human/rat/mouse, ABCAM, Cambridge, UK), CD206 (1:20 rat anti-mouse, clone MR5D3, BioLegend, San Diego, California, USA) and Ym1/2 (1:1,000 polyclonal rabbit antimouse, a kind gift of Dr. Shioko Kimura, NIH/NCI, Bethesda, USA). For the evaluation of CCR7 and ABCA1 expression, immunohistochemistry was performed using antibodies against mouse CCR7 (1:700 monoclonal rabbit anti-human/rat/mouse, clone Y59, ABCAM) and mouse ABCA1 (1:1,000 polyclonal rabbit anti-mouse, Novus Biological, Littleton, Colorado, USA). Briefly, sections were incubated with the primary antibody overnight at 4 o C, blocked for endogenous peroxidase with 3%H 2 O 2 and following several washes incubated with a secondary biotinylated anti-rat (1:100 rabbit anti-rat IgG, DAKO) or anti-rabbit (1:500 goat anti-rabbit IgG, Vector Laboratories, Burlingame, California, USA) antibody for 30 min at room temperature. Then, sections were incubated with streptavidin-HRP Ultrasensitive (1:1,000 Sigma-Aldrich, St. Louis, Missouri, USA) for 30 min at room temperature in the dark, and subsequently developed with DAB (Liquid DAB + Substrate chromogen System, DAKO). The sections were photographed and the stained area was quantified using ImageJ 1.41 software or positive cells were counted.
Serum Total Cholesterol and Triglycerides
At time of sacrifice, blood samples were collected from the vena cava of all mice. Total serum cholesterol and triglycerides were measured by enzymatic methods using an automated analyzer AU5400 -Chemistry System (Beckman Coulter, Brea, California, USA).
Lipoprotein isolation and modification
Human LDL and HDL were isolated from EDTA-plasma of healthy donors after overnight fasting by differential density ultracentrifugation on OTD Combi (Sorvall, Thermo Fisher Scientific, Waltham, Massachusetts, USA) over the density range of d 1.019 to 1.063 and 1.21 g/mL, respectively as described (Binder et al, 2003) . The quality of LDL-preparations was checked by lipoprotein electrophoresis. LDL was sterile filtered and stored at 4°C. CuOx-LDL and MDA-LDL were prepared as described previously (Binder et al, 2003) . Protein concentrations were determined by Lowry or BCA-method according to manufacturer's instructions (Pierce, Thermo Fisher Scientific). All lipoprotein preparations used for cell culture were tested for endotoxin levels by chromogenic Limulus amoebocyte assay (QCL-1000; BioWhittaker Inc, Wakersville, Maryland, USA) and contained less than 1 ng lipopolysaccharides/mg protein.
Macrophage foam cell assays
Isolation of peritoneal macrophages. For all in vitro experiments, C57BL/6J mice, 12-16 weeks of age, were injected intraperitoneally with 2 mL of 3% thioglycollate (Difco, Thermo Fischer Scientific). After 3 days, thioglycollate-elicited macrophages were harvested and plated in full culture medium (RPMI 1640 media, 100 U/mL penicillin, 100 µg/mL streptomycin and 50 µg/mL gentamicin; all Invitrogen, Carlsbad, California, USA) containing 10% heat-inactivated fetal calf serum (FCS) at a density of 3x10 (Fig 5B) or macrophages were loaded with 50 µg/mL CuOx-LDL plus 1 µCi [H 3 ]-cholesterol in full culture medium for 24 hours at 37 o C prior to macrophage differentiation with either 100 ng/mL IFN or 5 ng/mL IL-13, respectively in full culture medium for further 16 hours (Fig S7 of Support information) . Thereafter, cells were equilibrated in serum free-full culture medium for 2h at 37 o C. After equilibration, cells were incubated with or without 10 µg/mL HDL plus 50 µg/mL CuOx-LDL in serum free-full culture medium for 6 hours at 37 o C. Supernatants were collected and spun down (at 3,000 rpm for 10 min) to remove cellular debris, and the radioactivity in the supernatants was measured using a liquid scintillation counter (-counter 2000 CA; TRI-CARB Liquid Scintillation Analyzer, Packard). Cells were lysed in 0.1M NaOH and the cell-associated radioactivity was measured as described above. All measured counts were corrected for total cellular protein content as determined by the Bradford method (Bio-Rad Protein Assay, Bradford Laboratories, Hercules, California, USA). The percent efflux was calculated as (media dpm)/(cell+media dpm) x 100 and the HDL dependent-efflux was calculated as (mean % efflux with HDL)-(mean % efflux w/o HDL).
RNA/protein isolation. Following foam cell generation, total RNA was isolated using the RNeasy Mini Kit (PeqLab, Vienna, Austria) and 500 ng of total RNA was reversetranscribed using the High Capacity cDNA Reverse Transcription kit (Applied Biosystems, Carlsbad, California, USA). Quantitative real-time PCR was performed using iTaq SYBR Green Supermix with ROX Dye (Bio-Rad Laboratories, Hercules, California, USA) in a CFX96 Real-time System (Bio-Rad Laboratories). All data were normalized to Cyclin B (CycB) and expressed as fold change over control (untreated cells). Primer sequences are available in the Table SII . For protein detection, cells were incubated for 10 min at room temperature with a lysis buffer containing 62.5mM Tris, 8M Urea, 20mM EDTA, 20mM EGTA, 10% glycerol, 1% SDS (pH6.8), and lysates were sonicated for 2 seconds and stored at -20 o C for further analyses.
Immunoblotting
Samples were separated by SDS-PAGE and blotted on nitrocellulose-membranes (TransBlot ® Transfer Medium, Bio-Rad Laboratories). Membranes were blocked in 5% non-fat dry milk in TBS containing 0.1% Tween 20 for 60 min at room temperature. Following 3 washing steps, blots were probed using anti-ABCA1 (rabbit IgG anti-mouse, 1:500, Novus Biological) or anti-ABCG-1 (rabbit IgG anti-mouse, 1:2,000, Novus Biological) or anti--actin (mouse IgG2a anti-mouse, 1:5,000, Sigma-Aldrich) antibodies overnight in washing buffer (TBS + 0.1% Tween 20) containing 3 % BSA at 4 °C. After 3 washing steps, blots were incubated with a secondary HRP-labeled goat anti-rabbit (1:10,000, Sigma-Aldrich) or goat anti-mouse IgG (1:10,000, Bio-Rad Laboratories) in washing buffer containing 5% non-fat dry milk for 60 min at room temperature. After further washing, membranes were developed using a 1:1 solution of Luminol/Enhancer and Stable Peroxidase (Super Signal ® West Dura Extended Duration Chemiluminescent Substrate, Pierce Biotechnology, Rockford, Illinois, USA), and chemiluminescence was detected using a CCD camera (FUSION FX7, PEQLAB Biotechnologie GmbH, Erlangen, Germany). AlphaEase FC software (Alpha Innotech Corporation, San Leandro, California, USA) was used for quantification.
Splenocyte cytokine release assay
Total Splenocytes (0.25 × 10 5 ) were seeded into 96-well round-bottom plates in full culture medium containing 10% FCS in a final volume of 100 μl. Quadruplicate cultures of splenocytes from individual mice were incubated for 72 hours at 37°C/5% CO 2 either alone or in the presence of 10 μg/mL plate-bound anti-mouse CD3 (clone 145-2C11, BD Biosciences -Pharmingen) and 10 μg/mL soluble anti-mouse CD28 (clone 37.51, BD BiosciencesPharmingen) to induce maximal activation of T-cells. The amounts of INF-, IL-4, IL-5, IL-10 and IL-13 were determined by a fluorescent bead immunoassay in undiluted supernatants (FlowCytomix 5-plex kit, eBioscience, Vienna, Austria).
Flow Cytometry
At time of sacrifice, peritoneal exudate cells (PEC) were harvested by peritoneal lavage using ice-cold HBSS supplemented with 2% FCS. Total white blood cells were isolated from blood collected in EDTA-tubes via the vena cava. Blood was diluted 1:1 in a solution of PBS containing 2% Dextran (Sigma-Aldrich) and incubated for 40 min at 37 o C to separate the red blood cells. All cells were washed and incubated with an anti-Fcγ receptor blocking antibody (anti-mouse CD16/CD32, clone 93, 1:200, eBioscience) for 30 min at 4°C. T-cells, B-cells and macrophages in PEC were assessed using FITC-labeled anti-CD23 (clone B3B4, 1:800, BD Biosciences -Pharmingen), phycoerythrin (PE)-labeled anti-CD5 (clone 53-7.3, 1:100, eBioscience), PercP-labeled anti-CD19 (clone 1D3, 1:200, BD Biosciences -Pharmingen), and APC-labeled anti-CD11b/Mac-1 (clone M1/70, 1:800, eBioscience); macrophage subpopulations were determined using FITC-labeled anti-CD206 (clone MR5D3, 1:200, BioLegend), PE-labeled anti-CD80 (clone 16-10A1, 1:200, BD Bioscience -Pharmingen) and APC-labeled anti-F4/80 (clone BM8, 1:200, Invitrogen). Peripheral blood cells were analysed for the presence of resident monocytes, inflammatory monocytes, neutrophils and B cells using FITC-labeled anti-Ly6C (clone HK1.4, 1:200, BioLegend), PE-labeled anti-Ly6G (clone 1A8, 1:2000, BioLegend), PercP-labeled anti-CD19 (clone 1D3, 1:200, BD Biosciences -Pharmingen) and APC-labeled anti-CD11b/Mac-1 (clone M1/70, 1:800, eBioscience). All stains were performed in 100 μL of FACS buffer (PBS + 2% FCS) for 30 min at 4°C in darkness, followed by two washes. Stained cell populations were analyzed by multiparameter flow cytometry using a BD FACSCalibur (BD Bioscience, Franklin Lakes, New Jersey, USA). More than 10 5 cells were acquired per sample, with dead cells excluded by forward and side scatter properties and data were analyzed using FlowJo 7.6.4 software (Tree Star, Inc., Oregon Corporation, Ashland, Oregon, USA).
Immunoassays
Antibody titers to MDA-LDL were determined by chemiluminescent ELISA as previously described (Binder et al, 2003) . Total isotype levels were determined by a chemiluminescentbased sandwich ELISA using matched pairs of specific antibodies for capture and detection, followed by incubation steps with AP-conjugated NeutrAvidin (1:10,000 in TBS-BSA, Perkin Elmer) at room temperature and Lumiphos Plus (P-701, 30% solution in water, Lumigen, South Field, Michigan, USA). Chemiluminescence was detected using a luminescence reader (BioTek Synergy 2, BioTek, Winooski, Vermont, USA). The following antibodies were paired with appropriated AP-conjugated or biotinylated detecting antibodies, respectively: anti-mouse IgM (coated at 2 g/mL, Sigma-Aldrich) and AP-conjugated goat anti-mouse IgM (1:20,000 in TBS-BSA, Sigma-Aldrich), anti-mouse IgG1 (coated at 2 g/mL, BioLegend) and biotinylated anti-mouse IgG1 (at 0.5 µg/mL in TBS-BSA, BD Bioscience), anti-mouse IgG2c (coated at 1 g/mL, AbDSerotec, Oxford, United Kingdom) and biotinylated goat antimouse IgG2c (1:4,000 in TBS-BSA, Jackson ImmunoResearch Laboratories, West Grove, Pennsylvania, USA). Isotype levels were measured at following three serum dilutions: 1:10,000, 1:30,000 and 1:90,000 for IgM, 1:50,000, 1:150,000, 1:450,000 for IgG1 and 1:250,000, 1:500,000, 1:1,000,000 for IgG2c. Results were calculated on a standard curve, which was generated using respective purified isotypes obtained from Biolegend (IgM and IgG1) or Southern Biotech (IgG2c, SouthernBiotech, Birmingham, Alabama, USA).
Monocyte labeling and macrophage egression assessment
Macrophage emigration from atherosclerotic lesions were analyzed by a fluorescent labelledbead tracking technique previously described (Potteaux et al, 2011) . Twenty-two male, 8 weeks old, ApoE -/-mice (C57BL/6J background) were fed a standard western diet containing 21% fat and 0.2% cholesterol (Altromin Spezialfutter GmbH & Co.KG, Lage, Germany) for 6 weeks to induce lesion formation. At week 3, circulating classical Ly6C hi monocytes were labeled by intravenous (i.v) injection of 1 μm Fluoresbrite green fluorescent (YG) plain microspheres (Polysciences Inc., Warrington, Pennsylvania, USA) diluted 1:4 in sterile PBS, 24 hours after an i.v. injection of 250 μl clodronate-loaded liposomes to deplete monocytes. Mice were not manipulated for the following week to allow latex-beads + monocytes to accumulate within atherosclerotic plaques. At week 4, mice were divided into three groups randomly. One group was sacrificed for the quantification of bead and macrophage (mac-2 + cells) content (baseline, n=7); the remaining two groups received biweekly intraperitoneal injections of either PBS (n=7) or IL-13 (50 ng/mouse, R&D systems n=8) for the remaining 2 weeks. All animal experiments were approved by the local ethical committee (Regierung von Oberbayern). At the end of week 6, numbers of beads per plaque area in the aortic root and mac-2 + cells per total DAPI + cells were quantified in cross-sections of atherosclerotic lesions of PBS-and IL-13-treated mice. Macrophage egress was assessed by the number of beads present within the plaque area at the end of the experimental approach compared to baseline (week 4).
Intravital microscopy
Leukocyte endothelial interactions and expression of endothelial adhesion molecules were analyzed by intravital microscopy of the left carotid artery. Sixteen male, 8 weeks old, Cx 3 cr1 gfp/wt ApoE -/-mice (C57BL/6J background, for leukocyte endothelial interactions) and sixteen male, 8 weeks old, ApoE -/-mice (C57BL/6J background, for endothelial adhesion molecules expression) were fed a standard western diet containing 21% fat and 0.2% cholesterol (Altromin) for 6 weeks to induce lesion formation. At week 4, they were divided into two groups randomly and injected intraperitoneally with PBS (n=8) or IL-13 (50 ng/mouse, R&D systems n=8) twice per week for the remaining 2 weeks. At the end of this period, mice were anaesthetized with ketamine/xylazine and the left carotid artery was exposed as described previously (Drechsler et al, 2010) . All animal experiments were approved by the local ethical committee (Regierung von Oberbayern). Circulating leukocytes were labeled by injection of a PE-labeled anti-mouse Gr1 antibody (clone RB6-8C5, 5µg, eBioscience) via an intravenous catheder 5 min prior to recording. Intravital microscopy was performed using an Olympus BX51 microscope (Olympus, Hamburg, Germany) equipped with a beam splitter to enable synchronized dual-channel recording, a Hamamatsu 9100-02 EMCCD camera (Hamamatsu Photonics, Hamamatsu City, Japan), and a 10x salineimmersion objective. For image acquisition and analysis Olympus Cell r software was used. Adherent monocytes (GFP) and neutrophils (GFP -/PE + ) were recorded at the bifurcation. For luminal detection of VCAM-1 or CCL-2 presented on the endothelium, 50 µl of Protein G Fluoresbrite YG Micropheres (Polysciences Inc) were coupled to 50 g of polyclonal antibodies against mouse VCAM-1 (eBioscience) or mouse CCL2 (eBioscience) as described recently (Engel et al, 2011) . Antibody/bead complexes were injected intravenous and allowed to circulate for 15 min. Complexes immobilized along the carotid artery were detected by intravital microscopy as described above.
Statistical analysis
Statistical analyses were performed using GraphPadPrism 4.03 software (GraphPad Software, Inc., La Jolla, California, USA). Results were analyzed by one-way analysis of variance (ANOVA) with the post-test Bonferroni's multiple comparison tests for all the in vitro data. Student's unpaired t-test was used for results of in vivo studies (unless indicated differentially). Data are presented as mean ± SEM and P < 0.05 was considered significant. 
